BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am 2013;60:1489-511. [PMID: 24237984 DOI: 10.1016/j.pcl.2013.08.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville TO, Hossny E, Mazer B, Nelson R, Secord E, Jordan SC, Stiehm ER, Vo AA, Ballow M. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol 2017;139:S1-S46. [PMID: 28041678 DOI: 10.1016/j.jaci.2016.09.023] [Cited by in Crossref: 247] [Cited by in F6Publishing: 199] [Article Influence: 41.2] [Reference Citation Analysis]
2 Miano M. How I manage Evans Syndrome and AIHA cases in children. Br J Haematol 2016;172:524-34. [DOI: 10.1111/bjh.13866] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
3 Rao VK. Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome. Front Pediatr 2015;3:65. [PMID: 26258116 DOI: 10.3389/fped.2015.00065] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
4 Khandelwal P, Teusink-Cross A, Kumar AR, Bleesing JJ, Mehta PA, Jordan MB, Chandra S, Davies SM, Marsh RA. Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series. Br J Haematol 2021;194:e84-9. [PMID: 34046889 DOI: 10.1111/bjh.17565] [Reference Citation Analysis]
5 Knops N, Emonds MP, Herman J, Levtchenko E, Mekahli D, Pirenne J, Van Geet C, Dierickx D. Bortezomib for autoimmune hemolytic anemia after intestinal transplantation. Pediatr Transplant 2020;24:e13700. [PMID: 32166874 DOI: 10.1111/petr.13700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kühne T. Diagnosis and management of immune thrombocytopenia in childhood. Hamostaseologie 2017;37:36-44. [PMID: 27699328 DOI: 10.5482/HAMO-16-06-0017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Edington HJ, Sutton KS, Bennett C, Chandrakasan S, Sterner-Allison J, Castellino SM. Dealing with a critical national shortage-Approaches to triaging immune globulin supply in pediatric hematology and oncology. Pediatr Blood Cancer 2020;67:e28260. [PMID: 32329568 DOI: 10.1002/pbc.28260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Di Nardo G, Quitadamo P, Quatrini M, Malfona F, Moleti ML, La Rocca U, Velardi M, Parisi P, Testi AM. Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis. Inflamm Bowel Dis 2021;27:e63-4. [PMID: 33452802 DOI: 10.1093/ibd/izaa363] [Reference Citation Analysis]
9 Rivalta B, Zama D, Pancaldi G, Facchini E, Cantarini ME, Miniaci A, Prete A, Pession A. Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease. Front Pediatr 2019;7:304. [PMID: 31396497 DOI: 10.3389/fped.2019.00304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kim TO, Despotovic JM. Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children. Hematol Oncol Clin North Am 2019;33:489-506. [PMID: 31030815 DOI: 10.1016/j.hoc.2019.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rezaei N, Bonilla FA, Seppänen M, de Vries E, Bousfiha AA, Puck J, Orange J. Introduction on Primary Immunodeficiency Diseases. In: Rezaei N, Aghamohammadi A, Notarangelo LD, editors. Primary Immunodeficiency Diseases. Berlin: Springer Berlin Heidelberg; 2017. pp. 1-81. [DOI: 10.1007/978-3-662-52909-6_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Lube GE, Ferriani MP, Campos LM, Terreri MT, Bonfá E, Magalhães CS, Aikawa NE, Piotto DP, Peracchi OA, Dos Santos MC, Appenzeller S, Ferriani VP, Pereira RM, Silva CA. Evans Syndrome at Childhood-Onset Systemic Lupus Erythematosus Diagnosis: A Large Multicenter Study. Pediatr Blood Cancer 2016;63:1238-43. [PMID: 27018636 DOI: 10.1002/pbc.25976] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
13 Benčina M, Mavrič T, Junkar I, Bajt A, Krajnović A, Lakota K, Žigon P, Sodin-šemrl S, Kralj-iglič V, Iglič A. The Importance of Antibacterial Surfaces in Biomedical Applications. Elsevier; 2018. pp. 115-65. [DOI: 10.1016/bs.abl.2018.05.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Becheur M, Bouslama B, Slama H, Toumi N. Anémie hémolytique auto-immune de l’enfant. Transfusion Clinique et Biologique 2015;22:291-8. [DOI: 10.1016/j.tracli.2015.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Seidel MG. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood 2014;124:2337-44. [PMID: 25163701 DOI: 10.1182/blood-2014-06-583260] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 10.0] [Reference Citation Analysis]
16 Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood 2016;127:17-28. [PMID: 26504182 DOI: 10.1182/blood-2015-07-657981] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 14.3] [Reference Citation Analysis]
17 Allen CE. ALPS DNT cells: active senior living with mTOR. Blood 2016;128:152-152. [DOI: 10.1182/blood-2016-05-713032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Voulgaridou A, Kalfa TA. Autoimmune Hemolytic Anemia in the Pediatric Setting. J Clin Med 2021;10:E216. [PMID: 33435309 DOI: 10.3390/jcm10020216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Semo Oz R, S Tesher M. Arthritis in children with LRBA deficiency - case report and literature review. Pediatr Rheumatol Online J 2019;17:82. [PMID: 31847838 DOI: 10.1186/s12969-019-0388-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Johnson V, Burgess B, Morley P, Bragg R, Avery A, Dow S. Comparison of cytokine responses between dogs with sepsis and dogs with immune-mediated hemolytic anemia. Vet Immunol Immunopathol 2016;180:15-20. [PMID: 27692090 DOI: 10.1016/j.vetimm.2016.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
21 Abraham RS. How to evaluate for immunodeficiency in patients with autoimmune cytopenias: laboratory evaluation for the diagnosis of inborn errors of immunity associated with immune dysregulation. Hematology Am Soc Hematol Educ Program 2020;2020:661-72. [PMID: 33275711 DOI: 10.1182/hematology.2020000173] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Halsey NA, Talaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, Salmon DA. The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine 2015;33 Suppl 5:F1-F67. [PMID: 26822822 DOI: 10.1016/j.vaccine.2015.10.080] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
23 Sipurzynski J, Fahrner B, Kerbl R, Crazzolara R, Jones N, Ebetsberger G, Jauk B, Strenger V, Wohlmuther B, Schwinger W, Lackner H, Urban C, Holter W, Minkov M, Kager L, Benesch M, Seidel M. Management of chronic immune thrombocytopenia in children and adolescents: lessons from an Austrian national cross-sectional study of 81 patients. Seminars in Hematology 2016;53:S43-7. [DOI: 10.1053/j.seminhematol.2016.04.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
24 Harris EM, Hillier K, Al-Samkari H, Berbert L, Grace RF. Response to rituximab in children and adults with immune thrombocytopenia (ITP). Res Pract Thromb Haemost 2021;5:e12587. [PMID: 34466770 DOI: 10.1002/rth2.12587] [Reference Citation Analysis]
25 Huang Y, Jiang X, Han B. Effective treatment of refractory acquired pure red blood cell aplasia with eltrombopag and sirolimus: a case report. Ther Adv Hematol 2020;11:2040620720940144. [PMID: 32733663 DOI: 10.1177/2040620720940144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Callejas Caballero I, Illán Ramos M, Berzosa Sánchez A, Anguita E, Ramos Amador JT. Autoimmune neutropenia associated with influenza virus infection in childhood: a case report. BMC Infect Dis 2021;21:830. [PMID: 34407762 DOI: 10.1186/s12879-021-06506-9] [Reference Citation Analysis]
27 Kirk SE, Grimes AB, Shelke S, Despotovic JM, Powers JM. The cost of a "benign" condition: Healthcare utilization and infectious outcomes in young children with primary autoimmune neutropenia. Pediatr Blood Cancer 2020;67:e28146. [PMID: 31886613 DOI: 10.1002/pbc.28146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Malagón C, Gomez MDP, Mosquera C, Vargas C, Gonzalez T, Arango C, Martin L, Perez P, Amaya-uribe L, Molano-gonzalez N, Anaya J. Juvenile polyautoimmunity in a rheumatology setting. Autoimmunity Reviews 2019;18:369-81. [DOI: 10.1016/j.autrev.2018.11.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
29 Singh A, Jindal AK, Joshi V, Anjani G, Rawat A. An updated review on phenocopies of primary immunodeficiency diseases. Genes Dis 2020;7:12-25. [PMID: 32181272 DOI: 10.1016/j.gendis.2019.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
30 Seidel MG. Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs). Hematology Am Soc Hematol Educ Program 2020;2020:673-9. [PMID: 33275670 DOI: 10.1182/hematology.2020000153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 Aladjidi N, Fernandes H, Leblanc T, Vareliette A, Rieux-Laucat F, Bertrand Y, Chambost H, Pasquet M, Mazingue F, Guitton C, Pellier I, Roqueplan-Bellmann F, Armari-Alla C, Thomas C, Marie-Cardine A, Lejars O, Fouyssac F, Bayart S, Lutz P, Piguet C, Jeziorski E, Rohrlich P, Lemoine P, Bodet D, Paillard C, Couillault G, Millot F, Fischer A, Pérel Y, Leverger G. Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort. Front Pediatr 2015;3:79. [PMID: 26484337 DOI: 10.3389/fped.2015.00079] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
32 Rotz SJ, Kodish E. Ethical conundrums in pediatric genomics. Hematology Am Soc Hematol Educ Program 2018;2018:301-6. [PMID: 30504324 DOI: 10.1182/asheducation-2018.1.301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Weli M, Ben Hlima A, Belhadj R, Maalej B, Elleuch A, Mekki N, Gargouri L, Kamoun T, Barbouche MR, Mahfoudh A. Diagnosis and management of autoimmune hemolytic anemia in children. Transfus Clin Biol 2020;27:61-4. [PMID: 32280062 DOI: 10.1016/j.tracli.2020.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Pan SY, Chia YC, Yee HR, Fang Cheng AY, Anjum CE, Kenisi Y, Chan MK, Wong MB. Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases. Future Sci OA 2020;7:FSO648. [PMID: 33437514 DOI: 10.2144/fsoa-2020-0142] [Reference Citation Analysis]
35 Li H, Ji J, Du Y, Huang Y, Gu H, Chen M, Wu R, Han B. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study. Exp Hematol 2020;89:87-95. [PMID: 32771553 DOI: 10.1016/j.exphem.2020.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA. Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies. J Allergy Clin Immunol Pract 2016;4:1089-100. [PMID: 27836058 DOI: 10.1016/j.jaip.2016.08.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
37 Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000Res 2017;6:1928. [PMID: 29123652 DOI: 10.12688/f1000research.11545.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]